SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CardioThoracic Systems (CTSI)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Bob Jagow who wrote (160)1/31/1998 12:50:00 AM
From: Norm Franklin  Read Replies (1) of 207
 
Sounds interesting. Recall the discussion we had months ago about the full spectrum of available procedures, with angioplasty on one end, followed by stents, then beating heart bypasses, and finally on-pump procedures for the conventional bypass. This new procedure sounds like it fits between stents and beating heart full bypasses. It sounds like this is what you do if a stent doesn't do the trick, or if a stent implant looks too sketchy considering the condition of the artery. This is all conjecture on my part.

BTW, I sat next to someone who knew about the MIDCAB work going on at Washington Hospital Center. She seemed to indicate that this was not a second tier facility, but one of the leading bypass facilities in the Washington DC area. When is the POET study coming to a conclusion?

Norm
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News